Chop with rituximab-treatment option in CD20(+) NHL - Our experience

被引：0
|
作者：
Utracka-Hutka, B [1 ]
Polakiewicz-Gilowska, A [1 ]
Cedrych, I [1 ]
机构：
[1] M Sklodowska Curie Mem Inst, Ctr Oncol, Gliwice, Poland
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
397
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [1] FOLLICULAR NHL IN TREATMENT WITH R-CHOP AND RITUXIMAB FOR MAINTENANCE, OUR EXPERIENCE
    Nadal Paula, Ortega
    Jose David, Gonzalez San Miguel
    Khoury Cristina, Romero
    Mesa Susej, Guedes
    Maria del Carmen, Losada Castillo
    Martin Manuel, Tapia
    Fuertes Fernando, Fernandez
    Quintana Cristina, Lemes
    Ruiz Ylenia, Morales
    Jose Miguel, Bosch Benitez
    Gomez Mar, Caballero
    HAEMATOLOGICA, 2021, 106 (10) : 297 - 298
  • [2] CHOP chemotherapy with rituximab in DLBCL non-Hodgkin's lymphoma (NHL) - Our experience
    Utracka-Hutka, B
    Cedrych, I
    Polakiewicz-Gilowska, A
    Szelc, S
    ANNALS OF ONCOLOGY, 2005, 16 : 178 - 178
  • [3] The intensity of CD20 expression determines the outcome of rituximab treatment
    Novakovic, Barbara Jezersek
    Horvat, Mateja
    Prevodnik, Veronika Koboves
    Novakovic, Srdjan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S11 - S11
  • [4] Rituximab: A monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris
    El Tal, Abdul Kader
    Posner, Marshall R.
    Spigelman, Zachary
    Ahmed, A. Razzaque
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (03) : 449 - 459
  • [5] Loss of CD20 expression on CLL cells following treatment with rituximab
    Poirot, Brigitte
    Chedani, Hicham
    Abbed, Karim
    Tertian, Gerard
    Raphael, Martine
    Besson, Caroline
    HEMATOLOGIE, 2010, 16 (01): : 92 - 95
  • [6] Rituximab in CD20 positive multiple myeloma
    J M Bergua
    C Cabrera
    E G Arteta
    J Prieto
    Leukemia, 2008, 22 : 1082 - 1083
  • [7] Rituximab in CD20 positive multiple myeloma
    P Moreau
    L Voillat
    L Benboukher
    C Mathiot
    C Dumontet
    N Robillard
    O Hérault
    F Garnache
    R Garand
    N Varoqueaux
    H Avet-Loiseau
    J L Harousseau
    R Bataille
    Leukemia, 2007, 21 : 835 - 836
  • [8] Transient downmodulation of CD20 by rituximab.
    Jilani, I
    O'Brien, S
    Manshouri, T
    Thomas, DA
    Thomazy, VA
    Imam, M
    Naeem, S
    Verstovsek, S
    Kantarjian, H
    Giles, F
    Keating, M
    Albitar, M
    BLOOD, 2002, 100 (11) : 804A - 804A
  • [9] Rituximab in CD20 positive multiple myeloma
    Moreau, P.
    Voillat, L.
    Benboukher, L.
    Mathiot, C.
    Dumontet, C.
    Robillard, N.
    Herault, O.
    Garnache, F.
    Garand, R.
    Varoqueaux, N.
    Avet-Loiseau, H.
    Harousseau, J. L.
    Bataille, R.
    LEUKEMIA, 2007, 21 (04) : 835 - +
  • [10] Rituximab in CD20 positive multiple myeloma
    Bergua, J. M.
    Cabrera, C.
    Arteta, E. G.
    Prieto, J.
    LEUKEMIA, 2008, 22 (05) : 1082 - 1083
12345